Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
Shahram
F
F
Behçet's Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Tehran, Iran.
Davatchi
F
F
Chams
H
H
Nadji
A
A
Jamshidi
A
A
Akbarian
M
M
Gharibdoost
F
F
D001379:Azathioprine / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D031300:Retinal Vasculitis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D014606:Uveitis, Anterior / Q000188:drug therapy* / Q000209:etiology; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000209:etiology; D014792:Visual Acuity / Q000187:drug effects
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine